International Journal of Vasculitis

Submit Manuscript

Peer-reviewed · Open Access Pub

International Journal of Vasculitis

Inflammatory vascular disease · mechanisms to outcomes

International Journal of Vasculitis publishes peer-reviewed research on vasculitis — inflammatory disease of the blood vessels — in systemic and organ-specific presentations alike. Laboratory, translational, clinical, epidemiologic and methodological work are equally eligible; what a manuscript is judged on is the question it asks and the evidence it brings to it.

Read now

The current issue is Volume 1, Issue 1. Both records are open access and free to read.

Read the current issue

In the current issue

Volume 1, Issue 1, 2023 — 2 published records.

Case Report

Volume 1, Issue 1 · Pages 1–5 · Published 23 August 2023 · CC BY 4.0

Deficiency of Adenosine Deaminase Type 2 (ADA2) DADA2 Masquerade as Lupus

Bayan Almabadi, Hesham Alsuwat, Hasheema H Alsulami, Salma Alkhammash

King Abdullah Medical City, Makkah, Saudi Arabia

Case Report

Volume 1, Issue 1 · Pages 6–12 · Published 20 September 2023 · CC BY 4.0

A case of delayed allergy after cyanoacrylate closure of varicose veins, diagnosed by drug-induced lymphocyte stimulation test

Hiroyuki Suzuki, Mayuko Nakayama, Go Kuwahara, Hideichi Wada

Kashiwa Kousei General Hospital, Chiba, Japan; Fukuoka University School of Medicine, Fukuoka, Japan

What the journal publishes

Vasculitis is inflammatory disease of the blood vessels: a family of conditions in which immune activity injures the vessel wall and, through it, the organ the vessel supplies. The journal reads that field across mechanisms, classification, diagnosis, treatment and outcomes.

Mechanisms

The immune and vascular biology of vessel-wall injury.

Classification

The nomenclature, criteria and vessel-size frameworks that give these syndromes their names, and the work of separating a primary vasculitis from the conditions that resemble one.

Diagnosis

Histopathology, imaging, serology, genetic testing and candidate biomarkers, and how such findings are read together when a presentation overlaps other disease.

Treatment

Induction and maintenance of remission, immunosuppressive and biologic therapy, and the management of relapse and of treatment-related risk.

Outcomes

The course a disease takes.

Full statement

The Aims and Scope page sets out eligibility in detail, including vessel size, organ systems, populations and the forms of evidence the journal considers.

Publishing with this journal

Manuscripts are handled by the editorial office and assessed by independent reviewers. The route an author chooses does not change how the manuscript is read.

The article processing charge is USD 1,200, invoiced only after editorial acceptance. A student rate of USD 540 applies where eligibility is confirmed by the editorial office.

Review model
Single-blind by default; double-blind review is available on request.
Decisions
Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal.
Independence
Those decisions remain independent of fees, services, memberships, and roles.
One route
Authors must use only one submission route for the same manuscript.

Start here

Aims and Scope

What the journal considers, and on what evidence.

Archive

The complete published record.

Editorial Board

The editors responsible for scholarly oversight.

Instructions for Authors

What to prepare before submitting.

Submit Manuscript

The approved submission routes for this journal.

Menu